Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 30,259 | 18,143 | 16,113 | 47,184 | 26,545 |
| Depreciation Amortization | 18,958 | 11,197 | 9,355 | 5,990 | 4,999 |
| Income taxes - deferred | 13,858 | 3,383 | 20,188 | 9,229 | 5,752 |
| Accounts receivable | 35,456 | -21,890 | -34,873 | 19,094 | -30,017 |
| Accounts payable and accrued liabilities | -551 | 274 | 2,510 | 3,392 | -1,547 |
| Other Working Capital | 24,143 | -12,832 | -46,481 | 22,957 | -25,185 |
| Other Operating Activity | -25,155 | 41,368 | 45,373 | -9,825 | 49,323 |
| Operating Cash Flow | $96,968 | $39,643 | $12,185 | $98,021 | $29,870 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 1,966 | 63 | 6,518 | 0 |
| PPE Investments | -42,021 | -42,080 | -54,026 | -22,101 | -33,287 |
| Net Acquisitions | -25,873 | N/A | N/A | -17,873 | N/A |
| Other Investing Activity | 0 | 0 | 0 | 10,000 | 0 |
| Investing Cash Flow | $-67,894 | $-40,114 | $-53,963 | $-23,456 | $-33,287 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 62,000 | 13,547 | 27,522 | 15,000 | 57,183 |
| Debt Repayment | -62,774 | -10,227 | -15,494 | -33,291 | -48,648 |
| Common Stock Issued | 6,848 | 761 | 10,026 | 7,235 | 4,464 |
| Common Stock Repurchased | -213 | -5,906 | 0 | 0 | N/A |
| Other Financing Activity | 2,751 | 60 | -5,395 | 2,607 | 1,845 |
| Financing Cash Flow | $8,612 | $-1,765 | $16,659 | $-8,449 | $14,844 |
| Exchange Rate Effect | -14 | 1 | 1 | -21 | 24 |
| Beginning Cash Position | 141,666 | 143,901 | 169,019 | 102,924 | 91,473 |
| End Cash Position | 179,338 | 141,666 | 143,901 | 169,019 | 102,924 |
| Net Cash Flow | $37,672 | $-2,235 | $-25,118 | $66,095 | $11,451 |
| Free Cash Flow | |||||
| Operating Cash Flow | 96,968 | 39,643 | 12,185 | 98,021 | 29,870 |
| Capital Expenditure | -42,021 | -53,845 | -54,026 | -22,101 | -33,287 |
| Free Cash Flow | 54,947 | -14,202 | -41,841 | 75,920 | -3,417 |